Abstract
BACILLUS Calmette-Guérin (BCG) is of considerable value as a non-specific adjuvant in the immunotherapy of neoplasia1–6. Although the striking preponderance of macrophages at the site of rejection elicited by intralesional BCG is support for their function as effector cells, we present evidence here for an additional role of the macrophage. Under the influence of systemically (intravenously) administered BCG, macrophages markedly stimulated thymus-derived (T) killer cells involved in lymphocyte-mediated cytotoxicity (cell-mediated immunity, CMI) in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mathé, G., Rev. Fr. d'Etudes Clin. Biol., 13, 881 (1968).
Old, L. J., Benacerraf, B., Clarke, D. A., Carswell, E. A., and Stockert, E., Cancer Res., 21, 1281 (1961).
Simmons, R. L., and Rios, A., Science, 174, 591 (1971).
Weiss, D. W., Bonhag, R. S., and Leslie, P., J. Exp. Med., 124, 1039 (1966).
Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, jun., M. G., and Rapp, H. J., J. Nat. Cancer Inst., 49, 119 (1972).
Morton, D. L., Eilber, F. R., Joseph, W. L., Wood, W. C., Trahan, E., and Ketcham, A. S., Ann. Surg., 172, 740 (1970).
Brunner, K. T., Mauel, J., and Schindler, R., Immunology, 11, 499 (1966).
Miller, J. F. A. P., Brunner, K. T., Sprent, J., Russell, P. J., and Mitchell, G. F., Transplant. Proc., 3, 915 (1971).
Gery, I., Gershon, R. K., and Waksman, B. H., J. Exp. Med., 136, 128 (1972).
Gery, I., and Waksman, B. H., J. Exp. Med., 136, 143 (1972).
Gery, I., Kruger, J., and Spiesel, S. Z., J. Immunol., 108, 1088 (1972).
Stobo, J. D., Rosenthal, A. S., and Paul, W. E., J. Immunol., 108, 1 (1972).
Greaves, M. E., Roitt, I. M., Zamir, R., and Carnaghan, R. B. A., Lancet, 2, 1317 (1967).
Möller, G., and Kashiwagi, N., Immunology, 22, 441 (1972).
Andersson, J., Sjöberg, O., and Möller, G., Immunology, 23, 637 (1972).
Gershon, R. K., and Kondo, K., Immunology, 21, 903 (1971).
Yoshinaga, M., Yoshinaga, A., and Waksman, B. H., J. Exp. Med., 136 (1972).
Fölch, H., Yoshinaga, A., and Waksman, B. H., J. Immunol., (in the press).
Scott, M. T., Cell Immunol., 5, 469 (1972).
Allison, A. C., and Davies, A. J. S., Nature, 233, 330 (1971).
Evans, R., and Alexander, P., Nature, 236, 168 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MITCHELL, M., KIRKPATRICK, D., MOKYR, M. et al. On the Mode of Action of BCG. Nature New Biology 243, 216–218 (1973). https://doi.org/10.1038/newbio243216a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/newbio243216a0
This article is cited by
-
The immunologic and immunotherapeutics equelae of intraperitoneal BCG
Irish Journal of Medical Science (1983)
-
The negative systemic effect of BCGcw inoculated intraperitoneally
Cancer Immunology, Immunotherapy (1981)
-
Activation of macrophages by blastolysin
Bulletin of Experimental Biology and Medicine (1980)
-
Histopathological studies on antitumor effect of sporamycin
Cancer Chemotherapy and Pharmacology (1980)
-
Suppression of adjuvant disease by bacillusCalmette-Guérin (BCG)
Experientia (1975)